Skip to main content
. 2020 Aug 26;107(4):596–611. doi: 10.1016/j.ajhg.2020.08.001

Table 3.

Participants in the NC NEXUS Hearing Loss Cohort with Positive or Inconclusive Findings

NC NEXUS Participant NGS-NBS Result Diagnostic (Dx) Result Gene(s) Disease Association with Gene (Inheritance) Variant and (Predicted Protein Change) Zygosity in NC NEXUS Participant
HL003 abnormal positive SLC26A4 Pendred syndrome (AR) c.626G>T (p.Gly209Val); c.1151A>G (p.Glu384Gly) heterozygous for both variants
HL004 normal inconclusive VUS MARVELD2 MYO7A deafness 49 (AR); deafness 2 (AR); Usher type 1B (AR) MARVELD2 c.1183−1G>A (p.?); MYO7A c.5824G>A (p.Gly1942Arg) heterozygous for MARVELD2 variant; homozygous for MYO7A variant
HL010 abnormal positive USH2A Usher type 2A (AR) c.1256G>T (p.Cys419Phe); c.3686T>G (p.Leu1229) heterozygous for both variants
HL013 abnormal negative F11 factor XI deficiency (AR) c.1489C>T (p.Arg497); c.1608G>C (p.Lys536Asn) heterozygous for both variants
HL014 abnormal positive GJB2 deafness 1A (AR) c.35del (p.Gly12fs) homozygous
HL016 abnormal positive USH2A Usher type 2A (AR) c.4338_4339del (p.Cys1447fs); c.2299del (p.Glu767fs) heterozygous for both variants
HL017 abnormal positive TECTA deafness 8/12 (AD) c.5597C>T (p.Thr1866Met) heterozygous
HL021 abnormal negative DSC2 arrhythmogenic right ventricular dysplasia (ARVD11) (AD) c.631−2A>G (p.?) heterozygous
HL022 normal inconclusive VUS TMPRSS3 nonsyndromic hearing loss and deafness (AR) c.208del (p.His70fs); c.1151T>A (p.Met384Lys) heterozygous for both variants
HL025 normal inconclusive (heterozygous variant) GJB2 deafness (AR) c.35del (p.Gly12fs) heterozygous
HL026 normal inconclusive VUS LOXHD1; CEMIP; MYH14 hearing loss (AR or AD) LOXHD1 c.2914G>A (p.Glu972Lys); LOXHD1 c.3161C>T (p.Thr1054Met); CEMIP/KIAA1199 c.58C>T (p.Leu20Phe); MYH14 c.5942G>C (p.Gly1981Ala) heterozygous for all variants
HL027 normal inconclusive VUS SOX10 Waardenburg syndrome (AD) c.482G>A (p.Arg161His) heterozygous

The NC NEXUS participant column includes “HL” (indicating hearing loss cohort) followed by the participant number. Each row in the table represents one NC NEXUS participant. An abnormal NGS-NBS result was indicated by a likely pathogenic or pathogenic variant found in the newborn screen gene list. A positive diagnostic result was indicated by a likely pathogenic or pathogenic variant found in a gene on the hearing loss list. An inconclusive diagnostic result was indicated by any variant of uncertain significance (VUS) finding or a heterozygous variant found in a gene associated with an autosomal-recessive form of hearing loss. A negative diagnostic result indicated we did not detect any pathogenic or likely pathogenic variants or any VUS on the hearing loss gene list. Gene symbols are italicized. NGS-NBS, next-generation sequencing newborn screen; AR, autosomal-recessive pattern of inheritance; AD, autosomal-dominant pattern of inheritance.